HTSUY Projected Dividend Yield

ADR/Hisamitsu Pharmaceutical Co Inc ( OTCBB : HTSUY )

Hisamitsu Pharmaceutical is a pharmaceutical company. Along with its affiliates, Co. is mainly engaged in the pharmaceutical business in Japan and overseas. Co. is engaged in the manufacture and sale of pharmaceuticals and related products, including OTC products and ethical products. Co.'s principal product brands are called "SALONPASs®," "SALONSIP®," "ByeBye-FEVER®," "Lifecella®," "MOHRUS®" and "KEPLAT®." In addition, Co. is involved in the provision of urban cable television broadcasting and Internet connection services; the sale and rearing of experimental animals; and the non-life insurance agency and advertising agency businesses.

18 YEAR PERFORMANCE RESULTS